Patent Assignment
Reel/Frame 047708/0514
Merger
Recorded: 2018-11-30
Pages: 3
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Properties
(2)
Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
Application:
61/574,231 →
Use of (1R,5S)-(+)-1-(Naphthalen-2-Yl)-3-Azabicyclo{3.1.0}Hexane in the Treatment of Conditions Affected by Monoamine Neurotransmitters
PCT:
PCT/US2012/000335 ↗
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 30, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047708/0147 →
Assignment of Assignor's Interest
Nov 30, 2018
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 047708/0151 →
Assignment of Assignor's Interest
Nov 30, 2018
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 047708/0469 →